Buybacks · TTM to Jun 2026$3.72Blatest four quarters
Buyback yield5.0%repurchases ÷ market cap
Dividends · TTM to Jun 2026$1.62Bdividend yield 2.2%
Shareholder yield7.2%buybacks + dividends ÷ market cap
Shares outstanding · 5 yr−19.9%264M shares (2026)
Buybacks ÷ free cash flow41%payout incl. dividends 59%
Fiscal-year detail
From the cash-flow statement as reported, in USD. Negative repurchases mean net share issuance.
| Fiscal year | Repurchases | Dividends | Free cash flow |
|---|---|---|---|
| FY2025Dec 2025 | $3.62B | $1.61B | $8.39B |
| FY2024Dec 2024 | $7.03B | $1.57B | $8.96B |
| FY2023Dec 2023 | $2.28B | $1.45B | $10.2B |
| FY2022Dec 2022 | $7.61B | $1.38B | $7.36B |
| FY2021Dec 2021 | $7.74B | $1.34B | $6.04B |
| FY2020Dec 2020 | $4.04B | $15.0M | $9.26B |
| FY2019Dec 2019 | $1.99B | $15.0M | $8.44B |
Repurchases in FY2025 were −48.5% versus the prior year.
About Cigna Corp
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home…
- Market cap
- $74.6B
- P/E (trailing)
- 11.7×
- Fiscal year end
- December
- ISIN
- US1255231003
- Reporting currency
- USD
- Data updated
- Oct 10, 2026